WuXi Biologics Ireland: Pioneering Sustainable Biomanufacturing Through Purpose-Driven Innovation In an era where sustainability has become a defining metric of corporate integrity and resilience, WuXi Biologics Ireland stands out as…
UCB Highlights Robust Data on Generalized Myasthenia Gravis Therapies at 15th MGFA International Conference, Reinforcing Commitment to Patient-Centered Innovation UCB,a global biopharmaceutical leader specializing in immunology and neurology, has announced…
CMS Prepares Third Cycle of Drug Price Negotiations Under IRA as Trump Administration Revives Push to Lower U.S. Prescription Costs In a move that signals the growing momentum of federal…
Bayer Reaffirms 2025 Outlook Following Robust First-Quarter Performance, Showcases Strength in Pharmaceuticals and Strategic Advancements in Crop Science Bayer AG has started 2025 with a strong operational footing, underscoring confidence…
Aetna, National Alliance for Care at Home, and MissionCare Collective Partner to Strengthen the Direct Care Workforce in Illinois, Louisiana, and North Carolina In a bold and strategic move to…
AstraZeneca Unveils Expansive Respiratory Portfolio and Pioneering Clinical Data at ATS 2025 to Advance Care Across Asthma, COPD, and Inflammatory Lung Diseases AstraZeneca is poised to make a significant impact…
Merck to Unveil Broad Range of Clinical Advances Across 25+ Cancer Types at ASCO 2025 Merck (NYSE: MRK), known as MSD outside the United States and Canada, is set to…
TVC Partners with Norbrook to Bring Felanorm™ to Independent Veterinary Practices The Veterinary Cooperative (TVC), the premier group purchasing organization dedicated to supporting independent veterinary practices across the United States,…
Orca Bio Unveils New Leadership Team Changes Orca Bio, a late-stage biotechnology company dedicated to transforming the treatment landscape for patients through its cutting-edge high-precision cell therapies, has announced an…
Feinstein Institutes Study Vagus Nerve Stimulation for Obesity Obesity is one of the most pressing health challenges facing the modern world, with over a third of the global population affected…
Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage oncology-focused biotechnology company pioneering innovative immunotherapies, announced its consolidated…
Ten-Year Data Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer In a significant milestone for the treatment of early-stage HER2-positive breast cancer, Genentech, a member of the…
